Loading…
DeviceTalks West 2017 has ended
Tuesday, December 12 • 10:00am - 10:30am
Innovation story with Edwards Lifesciences's Stanton Rowe

Log in to save this to your schedule and see who's attending!

Feedback form is now closed.
In 1999, replacing a heart valve without opening up a patient's chest was a foreign concept that seemed destined for the dustbin of history. Cardiothoracic surgeons didn't think it would work and testing it on patients with aortic stenosis was as risky as it gets.

However, for Stanton Rowe, the son of a rocket engineer and medtech veteran, this was an opportunity to change the course of medicine.


Eighteen years later, transcatheter aortic valve replacement or TAVR, is one of the most exciting medical developments in the medical device industry and is saving lives as we speak. And so is Rowe, who now serves as the Chief Science Officer at Edwards Lifesciences, the Irvine, Calif.-based leader in this field.
MassDevice's Brad Perriello sits down with Rowe to discuss his career innovating everything from stents to TAVR. 

Speakers
avatar for Stanton Rowe

Stanton Rowe

Chief Scientific Officer, Edwards Lifesciences
Stanton J. Rowe has been chief scientific officer since 2008 and also serves as corporate vice president, advanced technology. He joined the company in 2004 when Edwards acquired Percutaneous Valve Technologies, a company he helped to found in 1999 and of which he served as president... Read More →


Tuesday December 12, 2017 10:00am - 10:30am
Hilton Orange County/Costa Mesa 3050 Bristol Street, Costa Mesa, CA 92626

Attendees (11)